Rapid Micro Biosystems (RPID) Shares Outstanding (Diluted Average) (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Shares Outstanding (Diluted Average) of $45.4 million in Q1 2026, up 1.69% quarter-over-quarter from $44.7 million in Q4 2025, and up 3.27% year-over-year from $44.0 million in Q1 2025.
Rapid Micro Biosystems' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $45.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 3.27% year-over-year to $45.4 million; the TTM figure through Mar 2026 stood at $45.4 million (up 3.27% YoY), while the FY2025 annual figure was $44.7 million, up 2.53% from the prior year.
- Shares Outstanding (Diluted Average) came in at $45.4 million for Q1 2026 at Rapid Micro Biosystems, up from $44.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $45.4 million in Q1 2026 to a low of $42.2 million in Q1 2022.
- A 5-year average of $43.5 million and a median of $43.2 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- Across the five-year window, Shares Outstanding (Diluted Average) jumped 6479.33% in 2022 and rose 1.01% in 2024, its largest moves.
- Rapid Micro Biosystems' Shares Outstanding (Diluted Average) stood at $42.5 million in 2022, then grew by 1.34% to $43.0 million in 2023, then climbed by 1.28% to $43.6 million in 2024, then advanced by 2.53% to $44.7 million in 2025, then advanced by 1.69% to $45.4 million in 2026.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $45.4 million, $44.7 million, and $44.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | 45.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.43 Mn |
| Dec 31, 2025 | 44.68 Mn |
| Sep 30, 2025 | 44.53 Mn |
| Jun 30, 2025 | 44.32 Mn |
| Mar 31, 2025 | 43.99 Mn |
| Dec 31, 2024 | 43.58 Mn |
| Sep 30, 2024 | 43.51 Mn |
| Jun 30, 2024 | 43.43 Mn |
| Mar 31, 2024 | 43.25 Mn |
| Dec 31, 2023 | 43.02 Mn |
| Sep 30, 2023 | 42.99 Mn |
| Jun 30, 2023 | 42.94 Mn |
| Mar 31, 2023 | 42.81 Mn |
| Dec 31, 2022 | 42.45 Mn |
| Sep 30, 2022 | 42.52 Mn |
| Jun 30, 2022 | 42.49 Mn |
| Mar 31, 2022 | 42.20 Mn |
| Dec 31, 2021 | 19.78 Mn |
| Sep 30, 2021 | 35.32 Mn |
| Jun 30, 2021 | 694,698.00 |
| Mar 31, 2021 | 641,371.00 |
| Dec 31, 2020 | 358,582.00 |
| Sep 30, 2020 | 354,341.00 |
| Jun 30, 2020 | 353,465.00 |